With high expectations on Provenge, Dendreon is 'sold' (again) in $832M deal
Dendreon — and its faded cancer star Provenge — is changing hands for the second time in less than two years.
Their new owner is Nanjing Xinbai …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
